|
 Kolkata | Hyderabad | New Delhi | Mumbai | Bangalore | Indore | Ahmedabad | Chennai | Gurgaon Contact: Dr. D R Agarwal (Director) 83/1 Beliaghata Main Road, Suite # 1C & 1D, 1st Floor, Subham Plaza Phone : +91 33 2363 3924/3925 Contact: Mr. N K Pandey (Director) 1-7-293, Mahatma Gandhi Road, Secunderabad - 500 003, Andhra Pradesh. Phone : +91 40 2784 4284 Contact: Mr. Sanjeev Sharma Phone: +91 - 124 - 2644207 Contact: Mr.G. Ravindra Kumar Contact: Mr. P Srirama Murthy Phone: +91 80 2248 5338 Contact: Mr. Yogesh Bhatnagar Contac: Mr. Vikaskumar Vyas (F) 91-2717-25 1200 Contact: Mr. NC Pavan Kumar Contact: Mr. Sanjeev Kumar Sharma Phone: +91 - 124 - 2644207 |
 Indian Government to restructure regulatory process for biosimilar drugs The Drug Controller General of India’s (DCGI) office is going to initiate a dialogue to reform regulatory process for biological drugs and biogenerics. These are known as biosimilars in Europe and US. .....more TATA sues Greenpeace over trademark infringement TATA Sons has filed a lawsuit against Greenpeace India, a non-governmental environmental organization, in the Delhi High Court claiming defamation and trademark infringement and sought Rs. 10 crore as compensation. ..........more Wal-Mart’s Best Price brand in dispute The world’s largest retailer, US-based Wal-Mart Stores Inc. which operates in India through Bharti-Walmart Pvt. Ltd is in a mess regarding its brand name. Bharti-Walmart Pvt. Ltd, a joint venture of Wal-Mart with Sunil Mittal’s Bharti Enterprises Ltd, ..........more |
